Cardiovascular Diseases Clinical Trials in New York, New York

15 studies are recruiting for cardiovascular diseases in New York, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

    This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure. The purpose of this study is to find out if a medicine called vicadrostat, when taken with empaglif…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    NYC Research Inc., New York, New York
    Locations
    1143 in total
    Run by
    Boehringer Ingelheim
  2. Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

    The goal of this study is to evaluate the safety and efficacy of the BrioVAD System by demonstrating non-inferiority to the HeartMate 3 Left Ventricular Assist System when used for the treatment of advanced, refractory, left ventricular heart failure.

    Stage
    Not phased
    Ages
    18 to 100
    Site
    NYU Langone Health, New York, New York
    Locations
    47 in total
    Run by
    BrioHealth Solutions, Inc.
  3. A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)

    The OPTIMAL randomized clinical trial has been designed to compare two imaging strategies and to test the hypothesis that a calcium modification strategy informed by coronary CT angiography (CCTA) will improve procedural efficiency and effectiveness compared with the current standard of care (IVUS-…

    Stage
    Not phased
    Ages
    18 to 85
    Site
    Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, New York, New York
    Locations
    14 in total
    Run by
    Fundación EPIC
  4. Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

    PREVENTABLE is a multi-center, randomized, parallel group, placebo-controlled superiority study. Participants will be randomized 1:1 to atorvastatin 40 mg or placebo. This large study conducted in community-dwelling older adults without cardiovascular disease (CVD) or dementia will demonstrate the …

    Stage
    Phase 4
    Ages
    75 and older
    Site
    VA New York Harbor Healthcare System, New York, New York
    Locations
    106 in total
    Run by
    Duke University
  5. Exercise Activity Intervention With Sensor-Based Engagement in Patients With Atrial Fibrillation

    Atrial fibrillation (AF) affects 1 in 4 individuals during their lifetime and continues to increase in frequency and impact. Exercise intervention has established benefits to improve AF symptoms and burden in clinical studies. However, lack of access to exercise programs has limited therapeutic ado…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Icahn School of Medicine at Mount Sinai, New York, New York
    Run by
    Icahn School of Medicine at Mount Sinai
  6. Global Paradise System US Post Approval Study

    The objective of the Global Paradise® System US Post Approval Study (US GPS) is to evaluate the real-world use of the Paradise Ultrasound Renal Denervation System indicated for patients who are unable to lower their blood pressure with lifestyle changes and medication. This system is comprised of a…

    Stage
    Not phased
    Ages
    18 and older
    Site
    NYU Langone Health - Bellevue Hosptial, New York, New York
    Locations
    43 in total
    Run by
    ReCor Medical, Inc.
  7. The TRICURE EFS Study

    Prospective, multi-center study to assess safety and performance of the TRiCares Topaz Tricuspid Valve Replacement System

    Stage
    Not phased
    Ages
    18 and older
    Site
    Columbia University Medical Center/ NewYork Presbyterian Hospital, New York, New York
    Locations
    10 in total
    Run by
    TRiCares
  8. Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

    The purpose of TEAM-HF IDE clinical trial is to evaluate safety and effectiveness of the HeartMate 3 LVAS compared to guideline directed medical therapy (GDMT) in a population of ambulatory advanced heart failure patients who are not dependent on intravenous inotrope.

    Stage
    Not phased
    Ages
    18 and older
    Site
    New York-Presbyterian/Columbia University Medical Center, New York, New York
    Locations
    68 in total
    Run by
    Abbott Medical Devices
  9. Pivotal Study for the Cardiac Performance System (CPS)

    This multi-center, observational study evaluates the accuracy of the Cardiac Performance System (CPS), a non-invasive device, for measuring hemodynamic parameters in adult patients undergoing clinically indicated right heart catheterization. The study compares CPS measurements to invasive measureme…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York, New York
    Locations
    10 in total
    Run by
    Sensydia Corporation
  10. HARP Mindfulness Study

    This study was designed using the Multiphase Optimization Strategy (MOST) framework to determine whether two supplemental components increase the efficacy of a mindfulness-based cognitive therapy program delivered via telephone (MBCT-T) for psychological distress. Specifically, this study will test…

    Stage
    Not phased
    Ages
    18 and older
    Site
    NYU Langone Health, New York, New York
    Run by
    NYU Langone Health
  11. The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR

    The objective of this prospective, randomized, double- blinded (patient and assessors), sham-controlled clinical trial is to assess the safety and efficacy of the CMCS in treating heart failure with functional regurgitation (FMR).

    Stage
    Not phased
    Ages
    18 and older
    Site
    Northwell Staten Island, New York, New York
    Locations
    92 in total
    Run by
    Cardiac Dimensions, Inc.
  12. A Pilot Feasibility and Acceptability Study of Remote ExerciSe Training mOdalities (PRESTO)

    This study will investigate the acceptability and efficacy of 12 weeks of: Smart-device app-based (MyZone) Asynchronous Virtual, Synchronous Virtual, and in-person aerobic training in individuals at risk for Cardiovascular Disease (CVD) who do are not meeting American Heart Association (AHA) guidel…

    Stage
    Not phased
    Ages
    45 and older
    Site
    NYU Langone Health, New York, New York
    Run by
    NYU Langone Health
  13. Food and Microbiome Longitudinal Investigation (FAMiLI)

    The NYU Human Microbiome Study Cohort is designed to improve understanding of the role of human microbiome in health and disease. This study will serve as a critical NYU biorepository resource for research on human genetics and the microbiome in health and disease

    Stage
    Not phased
    Ages
    40 and older
    Site
    New York University School of Medicine, New York, New York
    Run by
    NYU Langone Health
  14. MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels

    This is a multicenter, randomized, single-blind pivotal study to evaluate the safety and efficacy of the MagicTouchTM Drug coated balloon in treatment of small vessels in patients with coronary artery disease. The objective is to establish the safety and efficacy of the Magic TouchTM Drug coated ba…

    Stage
    Not phased
    Ages
    18 to 80
    Site
    Icahn School of Medicine at Mount Sinai/ Mount Sinai Hospital, New York, New York
    Locations
    24 in total
    Run by
    Concept Medical Inc.
  15. MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

    A Prospective, Multicenter, Randomized, Two-Arm, Single-blind Superiority Trial to Evaluate the Safety and Efficacy of the MagicTouch™ Sirolimus- Coated Balloon in the Treatment of Coronary Drug-Eluting Stent In-Stent Restenosis. Subjects with prior DES implantation presenting with ISR lesions unde…

    Stage
    Not phased
    Ages
    18 to 110
    Site
    VA New York Harbor Healthcare System, New York, New York
    Locations
    28 in total
    Run by
    Concept Medical Inc.

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.